Home » Topics » Regulatory » Patents

Patents
RSS

Merck KGaA reports new P70S6K inhibitors

March 1, 2012

Novel ALK inhibitors created with anticancer potential

March 1, 2012

Amgen divulges novel beta-secretase 1 inhibitors

March 1, 2012

Merck & Co. designs new products with potential to treat hepatitis C

March 1, 2012

Wakunaga and NeuGen Pharma present new agents for neurological disorders

Feb. 29, 2012

Medexis reports new products with potential to treat cancer

Feb. 29, 2012

New cyclopropylamine derivatives designed at Oryzon Genomics

Feb. 29, 2012

Novel 5-lipoxygenase inhibitors disclosed by Ranbaxy Laboratories

Feb. 29, 2012

Merck & Co. patents novel products with potential to prevent herpes zoster

Feb. 29, 2012

AnaptysBio describes new antibodies targeting IL-17

Feb. 29, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...